Easier access to mechanical ventilation worldwide: an urgent need for low income countries, especially in face of the growing COVID-19 crisis Source: Eur Respir J, 55 (6) 2001271; 10.1183/13993003.01271-2020 Year: 2020
Research priorities for TB elimination low prevalence countries Source: School Course 13 Year: 2013
Countrywide implementation of whole genome sequencing: an opportunity to improve tuberculosis management, surveillance and contact tracing in low incidence countries Source: Eur Respir J, 51 (6) 1800387; 10.1183/13993003.00387-2018 Year: 2018
Using a rapid prioritisation process to identify health research priorities in LMICs Source: International Congress 2018 – Primary care management of COPD Year: 2018
Survey on health system aspects concerning malignant diseases (lung cancer) in limited health resources country Source: Annual Congress 2008 - Various aspects of thoracic oncology Year: 2008
Mandatory tuberculosis case notification in high tuberculosis-incidence countries: policy and practice Source: Eur Respir J 2016; 48: 1571-1581 Year: 2016
The effect of respiratory comorbidities on the provision of cessation assistance in six EU countries: are clinicians doing enough? Source: International Congress 2018 – EUREST-PLUS: implementation of the tobacco control policy to reduce lung disease Year: 2018
MDR-TB in Eastern Europe: new public health interventions Source: International Congress 2016 – The problem of multidrug-resistant tuberculosis Year: 2016
Suboptimal asthma control: prevalence, detection and consequences in general practice Source: Eur Respir J 2008; 31: 320-325 Year: 2008
Health status burden of COPD - comparison across different countries and treatment settings Source: Eur Respir J 2005; 26: Suppl. 49, 56s Year: 2005
Increasing burden of COPD in rural India: an example why India warrants primary healthcare reforms Source: ERJ Open Res 2016: 00032-2016 Year: 2016
Demographics, clinical characteristics, health resource utilization and cost of patients with CTEPH: Retrospective results from six European countries Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012
Digital health technology for the end TB strategy: Developing priority products and making them work Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016
Knowledge and management of tuberculosis among general practitioners in a high burden developing country Source: Eur Respir J 2006; 28: Suppl. 50, 377s Year: 2006
Low real-world utility of IGRA when screening for LTBI in a low incidence setting Source: International Congress 2015 – Screening strategies in TB Year: 2015
Screening immigrants to Ireland from countries with a high prevalence of tuberculosis would be clinically beneficial and cost effective Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013
Preventable deaths and better outcomes in CF: Need for organising care at European standards in developing countries Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies Year: 2011
Cohort analysis of a large community-based latent tuberculosis screening and treatment programme in a high incidence setting in East London Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016
Infection control measures on respiratory infections at the primary health care in Kyrgyz Republic: Current situation, prospects and impact on improvement of the health services quality Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care Year: 2013
Health outcomes assessment and economic evaluation in COPD: challenges and opportunities Source: Eur Respir J 2003; 21: 1S-3S Year: 2003